Some Medtronic Insulin Pumps Can Be Hacked, FDA Warns
An unsettling report at Reuters centers on certain types of MiniMed pump systems made by Medtronic, which the Food and Drug Administration warned on Tuesday may be vulnerable to cyberattacks, impacting insulin delivery to patients with diabetes.
Reuters:
FDA Warns Of Cybersecurity Risk With Certain Medtronic Insulin Pumps
The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic were vulnerable to cyberattacks and that hackers could potentially hamper insulin delivery by accessing the device. The agency issued a cybersecurity risk alert for the Medtronic MiniMed 600 Series insulin pump system, which has several components including an insulin pump and a blood glucose meter that communicate wirelessly. (9/21)
In other pharmaceutical industry news —
Houston Chronicle:
TMC Plans To Build Massive Biomanufacturing, Distribution Center
The Texas Medical Center plans to build a 500-acre biomanufacturing and medical supplies distribution center in Houston, a project that represents the latest push to establish the city as a premier hub for life sciences. The new campus, called TMC BioPort, is still in the early stages of development. But once it's completed, it’s expected to double the overall size of the medical center and create 100,000 jobs for Greater Houston residents, TMC President and CEO Bill McKeon said. (MacDonald, 9/21)
USA Today:
Adderall Shortage 2022: Limited Supplies Hit Two More US Drug Makers
Lannett Co. and Par Pharmaceuticals are the most recent companies experiencing with limited supplies of generic extended-release Adderall, according to the University of Utah Pharmacy Services website, which tracks drug shortages nationwide. More than six in 10 small pharmacies reported having difficulty in August obtaining the medication, a survey from the National Community Pharmacists Association found. (Neysa Alund, 9/21)
Newsweek:
Antidepressants Work Better Than Sugar Pills Only 15 Percent Of The Time
Hailed as a revolution for the treatment of depression when they first came out in the 1980s, SSRIs have become a mainstay of mental health treatment. Family doctors with little psychiatric training now prescribe them for adults and children alike. In 2019, one in eight Americans—43 million in all—were taking an SSRI, and those numbers have likely risen among a public ridden with COVID-induced anxiety. During the pandemic, doctors phoned in so many new prescriptions for Zoloft, the FDA warned of a drug shortage. Evidence is mounting, however, that doctors are vastly overprescribing SSRIs. (Piore, 9/21)
NPR:
Why Mosquitoes Were The Vaccinators In A New Malaria Vaccine Trial
One Seattle morning, Carolina Reid sat in a room with nine other volunteers, each waiting to take part in a clinical trial for a new, experimental malaria vaccine. Reid's turn came. She put her arm over a cardboard box filled with 200 mosquitoes and covered with a mesh that keeps them in but still lets them bite. "Literally a Chinese food takeout container" is how she remembers it. A scientist then covered her arm with a black cloth, because mosquitoes like to bite at night. Then the feeding frenzy began. (Barnhart, 9/21)
Stat:
Researchers Show They Can Quickly Turn CAR-T Cells On And Off
Researchers reported Wednesday that they could quickly and reliably turn CAR-T cells on and off in cancer patients, giving scientists an unprecedented level of control over this potent — but at times dangerous — oncology therapy. (Wosen, 9/21)
